Current market catalysts

Buyout Debt Is Surging to Levels Not Seen Since Before the Financial Crisis

Bankers are looking to sell off approximately $138 billion of buyout debt in the coming months, according to JPMorgan.

8-K filing — X4 Pharmaceuticals, Inc (XFOR)

Filed: 2026-09-09 AccNo: 0001501697-26-000076 Size: 2 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — Bit Digital, Inc (BTBT)

Filed: 2026-09-09 AccNo: 0001213900-26-098132 Size: 18 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today

Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 15 years by 4.89% on an annualized basis producing an average annual return of 18.08%. Currently, Royalty Pharma has a market capitalization of

'Blackstone’s Head of Real Estate Is Leaving the Firm'- WSJ

QUICK SPARK: LIV Golf’s $1 Billion Debt Problem Triggers Bankruptcy Filing

LIV Golf’s push to bring outside investors into its teams has taken on new urgency after the league filed for Chapter 11 bankruptcy.

8-K filing — Sound Point Meridian Capital, Inc. (SPMA)

Filed: 2026-09-08 AccNo: 0001829126-26-009903 Size: 253 KB Item 8.01: Other Events

8-K/A filing — Vivos Therapeutics, Inc. (VVOS)

Filed: 2026-09-08 AccNo: 0001493152-26-041807 Size: 241 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

8-K filing — Ellington Credit Co (ELLA)

Filed: 2026-09-08 AccNo: 0001628280-26-060947 Size: 179 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — Chime Financial, Inc. (CHYM)

Filed: 2026-09-08 AccNo: 0001193125-26-385383 Size: 776 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Ellington Financial Inc. (EFC-PC)

Filed: 2026-09-08 AccNo: 0001628280-26-060946 Size: 211 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — MURPHY OIL CORP (MUR)

Filed: 2026-09-08 AccNo: 0000950103-26-013671 Size: 13 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Ocugen, Inc. (OCGN)

Filed: 2026-09-08 AccNo: 0001104659-26-105968 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — REPLIGEN CORP (RGEN)

Filed: 2026-09-08 AccNo: 0001193125-26-385380 Size: 151 KB Item 8.01: Other Events

8-K filing — Nerdy Inc. (NRDY)

Filed: 2026-09-08 AccNo: 0001819404-26-000097 Size: 173 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

8-K filing — Estrella Immunopharma, Inc. (ESLAW)

Filed: 2026-09-08 AccNo: 0001213900-26-098123 Size: 242 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Milestone Scientific Files Prospectus To Offer Securities Up To $45M

Casey's General Stores Stock Tumbles After Q1 Earnings

Caseys General Stores Inc (NASDAQ:CASY) shares are moving lower in extended trading Tuesday on the heels of the company's first-quarter results.

8-K filing — Hepion Pharmaceuticals, Inc. (CTRVP)

Filed: 2026-09-08 AccNo: 0001493152-26-041801 Size: 945 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

8-K filing — Stimcell Energetics Inc. (STME)

Filed: 2026-09-08 AccNo: 0001493712-26-000012 Size: 207 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Worthington Steel, Inc. (WS)

Filed: 2026-09-08 AccNo: 0001193125-26-385371 Size: 283 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — CONSTELLATION BRANDS, INC. (STZ)

Filed: 2026-09-08 AccNo: 0000016918-26-000034 Size: 597 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

JIN MEDICAL INTERNATIONAL Says Will Obtain Contractual Control Over, Right To Receive Substantially All Economic Benefits Of, Huaxia Qiying Through VIE Agreements; Co, Erhua Med Will Not Acquire Legal Title To Equity Interests Of Chenglan Kangxu Or Huaxia Qiying Solely As A Result Of VIE Agreements; Agreement Provides For Aggregate Consideration Of $159.4M For Integrated Transaction

$1000 Invested In AMETEK 15 Years Ago Would Be Worth This Much Today

AMETEK (NYSE:AME) has outperformed the market over the past 15 years by 2.87% on an annualized basis producing an average annual return of 16.06%. Currently, AMETEK has a market capitalization of $54.50 billion. Buying

8-K filing — 5C Lending Partners Corp.

Filed: 2026-09-08 AccNo: 0000930413-26-002858 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

8-K filing — FREEPORT-MCMORAN INC (FCX)

Filed: 2026-09-08 AccNo: 0000831259-26-000038 Size: 143 KB Item 8.01: Other Events

8-K filing — Perspective Therapeutics, Inc. (CATX)

Filed: 2026-09-08 AccNo: 0001193125-26-385362 Size: 24 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Why Today's AI Boom Differs From the Internet Bubble

The article argues that the current AI buildout, representing the largest industrial expansion since 19th-century railroads, is fundamentally different from the 1990s internet bubble. Unlike the dot-com era where 90% of fiber infrastructure sat unused and 75% of IPOs operated at losses, today's AI companies are profitable, have reasonable valuations, and their hardware is in high demand with premium pricing. This suggests the AI boom has a stronger economic foundation than the internet bubble.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

Pomerantz LLP has filed a class action lawsuit against Capricor Therapeutics for alleged securities fraud related to its Deramiocel BLA submission to the FDA. The FDA's briefing documents revealed that Capricor altered its statistical analysis plan one day before data unblinding without FDA approval, leading the FDA to deem the analyses as 'post-hoc and exploratory.' Following the FDA's negative assessment on July 27, 2026, Capricor's stock plummeted 64%, and an advisory committee voted 9-3 against the drug's efficacy on July 30, 2026, causing an additional 36% stock decline.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Flotek Industries, Inc. of Class Action Lawsuit and Upcoming Deadlines – FTK

Pomerantz Law Firm has filed a class action lawsuit against Flotek Industries (NYSE: FTK) alleging securities fraud. The lawsuit stems from Flotek's announcement of a $400M contract with Puerto Rico's Electric Power Authority (PREPA) on August 3, 2026, which was subsequently canceled on August 18, 2026. Wolfpack Research reported that the contract was terminated due to unauthorized use of another contractor's signature and federal regulatory concerns. Flotek's stock fell 20.01% on August 17 and an additional 5.72% on August 18. Investors have until October 26, 2026, to request Lead Plaintiff status.